Aris Water Solutions (NYSE:ARIS) Hits New 52-Week High at $17.95

Maxim Group Cuts INmune Bio (NASDAQ:INMB) Price Target to $8.00



Maxim Group reduced their target price on shares of INmune Bio from $30.00 to $8.00 and set a “buy” rating for the company in a report on Wednesday.



Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *